Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS
No-Receipt date
2022-00458 - 09/02/2022
No-Filing date
20220400299 - 09/02/2022
No-Granting date
3109709 - 28/02/2022
No-EPO application date
17800310.9 - 19/05/2017
No-EPO granting date
3458053 - 08/12/2021
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
2/2022 - 09/03/2022
Expiration date
20/05/2037
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201662339433 P20/05/2016/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
C07D 277/82
A61P 35/00
A61K 31/428
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1413015
BIOHAVEN THERAPEUTICS LTD.
215 CHURCH STREET
NEW HAVEN
CT 06510
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
3578169
CORIC, VLADIMIR
Representatives
Code
Firstname
Surname
Address
Town
Zip
3712
ANTHOULA
GALANOPOULOU
THESI LYSI MPITAKOU
KAPANDRITI (ATTIKIS)
19014
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
9219
ALKISTIS-EIRINI
MALAMI
VISSARIONOS 3
ATHINA (ATTIKIS)
10672
GREECE
Owners History
Title Instruments
Payments history
9 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).